These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27370541)

  • 1. Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis Patients.
    Mameli G; Cossu D; Caggiu E; Arru G; Niegowska M; Cocco E; Frau J; Marrosu MG; Sechi LA
    J Mol Neurosci; 2016 Sep; 60(1):91-3. PubMed ID: 27370541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients.
    Mameli G; Cocco E; Frau J; Arru G; Caggiu E; Marrosu MG; Sechi LA
    Sci Rep; 2016 Jul; 6():29268. PubMed ID: 27383531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.
    Krumbholz M; Faber H; Steinmeyer F; Hoffmann LA; Kümpfel T; Pellkofer H; Derfuss T; Ionescu C; Starck M; Hafner C; Hohlfeld R; Meinl E
    Brain; 2008 Jun; 131(Pt 6):1455-63. PubMed ID: 18474519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production.
    Hedegaard CJ; Sellebjerg F; Krakauer M; Hesse D; Bendtzen K; Nielsen CH
    Mult Scler; 2011 May; 17(5):567-77. PubMed ID: 21177756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients.
    Frau J; Cossu D; Coghe G; Lorefice L; Fenu G; Porcu G; Sardu C; Murru MR; Tranquilli S; Marrosu MG; Sechi LA; Cocco E
    J Neurol Sci; 2015 Feb; 349(1-2):249-50. PubMed ID: 25598492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium avium subsp. paratuberculosis and multiple sclerosis in Sardinian patients: epidemiology and clinical features.
    Frau J; Cossu D; Coghe G; Lorefice L; Fenu G; Melis M; Paccagnini D; Sardu C; Murru MR; Tranquilli S; Marrosu MG; Sechi LA; Cocco E
    Mult Scler; 2013 Oct; 19(11):1437-42. PubMed ID: 23439580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of BAFF and TRAIL expression levels in multiple sclerosis patients: evaluation of expression under immunomodulatory therapy.
    Kurne A; Guc D; Canpinar H; Aydin OF; Sayat G; Yörübulut M; Esendagli G; Karabudak R
    Acta Neurol Scand; 2011 Jan; 123(1):8-12. PubMed ID: 20456241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAFF is a biological response marker to IFN-beta treatment in multiple sclerosis.
    Gandhi KS; McKay FC; Schibeci SD; Arthur JW; Heard RN; Stewart GJ; Booth DR
    J Interferon Cytokine Res; 2008 Sep; 28(9):529-39. PubMed ID: 18715196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population.
    Vaknin-Dembinsky A; Brill L; Orpaz N; Abramsky O; Karussis D
    Mult Scler; 2010 Dec; 16(12):1453-7. PubMed ID: 20935029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti Mycobacterium avium subsp. paratuberculosis heat shock protein 70 antibodies in the sera of Sardinian patients with multiple sclerosis.
    Cossu D; Masala S; Frau J; Cocco E; Marrosu MG; Sechi LA
    J Neurol Sci; 2013 Dec; 335(1-2):131-3. PubMed ID: 24075312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients.
    Cossu D; Mameli G; Galleri G; Cocco E; Masala S; Frau J; Marrosu MG; Manetti R; Sechi LA
    Mult Scler; 2015 Jul; 21(8):984-95. PubMed ID: 25392335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome.
    Kannel K; Alnek K; Vahter L; Gross-Paju K; Uibo R; Kisand KV
    PLoS One; 2015; 10(11):e0143393. PubMed ID: 26600308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are Mycobacterium avium subsp. paratuberculosis and Epstein-Barr virus triggers of multiple sclerosis in Sardinia?
    Cossu D; Masala S; Cocco E; Paccagnini D; Frau J; Marrosu MG; Sechi LA
    Mult Scler; 2012 Aug; 18(8):1181-4. PubMed ID: 22261119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors?
    Frau J; Cossu D; Sardu C; Mameli G; Coghe G; Lorefice L; Fenu G; Tranquilli S; Sechi LA; Marrosu MG; Cocco E
    BMC Neurol; 2016 Aug; 16(1):148. PubMed ID: 27552900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients.
    Mameli G; Cocco E; Frau J; Marrosu MG; Sechi LA
    Sci Rep; 2016 Mar; 6():22401. PubMed ID: 26956729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
    Stewart N; Simpson S; van der Mei I; Ponsonby AL; Blizzard L; Dwyer T; Pittas F; Eyles D; Ko P; Taylor BV
    Neurology; 2012 Jul; 79(3):254-60. PubMed ID: 22700816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.
    Órpez-Zafra T; Pavía J; Hurtado-Guerrero I; Pinto-Medel MJ; Rodriguez Bada JL; Urbaneja P; Suardíaz M; Villar LM; Comabella M; Montalban X; Alvarez-Cermeño JC; Leyva L; Fernández Ó; Oliver-Martos B
    Mult Scler; 2017 Jun; 23(7):937-945. PubMed ID: 27613121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients.
    Weber F; Cepok S; Wolf C; Berthele A; Uhr M; Bettecken T; Buck D; Hartung HP; Holsboer F; Müller-Myhsok B; Hemmer B
    Pharmacogenomics J; 2012 Jun; 12(3):238-45. PubMed ID: 21502966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients.
    Asadikaram G; Noroozi S; Ebrahimi Meimand HA; Sanjari M; Zainodini N; Khoramdelazad H; Shahrokhi N; Kazemi Arababadi M
    Neuroimmunomodulation; 2016; 23(5-6):345-351. PubMed ID: 28433998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of antibodies against PtpA and PknG secreted by Mycobacterium avium ssp. paratuberculosis are present in neuromyelitis optica spectrum disorder and multiple sclerosis patients.
    Slavin YN; Bo M; Caggiu E; Sechi G; Arru G; Bach H; Sechi LA
    J Neuroimmunol; 2018 Oct; 323():49-52. PubMed ID: 30196833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.